Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Endocrinology ; 141(11): 4194-201, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11089553

ABSTRACT

Glucagon-like peptide-2 (GLP-2) is secreted by enteroendocrine cells in the small and large intestines and exerts intestinotropic effects in the gastrointestinal mucosal epithelium of the adult rodent. The actions of GLP-2 are mediated by the GLP-2 receptor, a new member of the G protein-coupled receptor superfamily. To ascertain whether the GLP-2/GLP-2 receptor axis is expressed and functional in the developing intestine, we have studied the synthesis of GLP-2 and the expression of the GLP-2 receptor (GLP-2R) in the fetal and neonatal rat gut. GLP-2 immunoreactivity (GLP-2-IR) was detected in the fetal rat intestine, and fetal rat intestinal cell cultures secreted correctly processed GLP-2(1-33) into the medium. High levels of GLP-2(1-33) were also detected in the circulation of 13-day-old neonatal rats (P < 0.001 vs. adult). Analysis of GLP-2 receptor expression by RT-PCR demonstrated GLP-2R messenger RNA transcripts in fetal intestine and in neonatal stomach, jejunum, ileum, and colon. The levels of GLP-2R messenger RNA transcripts were comparatively higher in the fetal and neonatal intestine (P < 0.05-001 vs. adult) and declined to adult levels by postnatal day 21. Subcutaneous administration of a degradation-resistant GLP-2 analog, h[Gly2]-GLP-2 once daily for 10 days increased stomach (0.009 +/- 0.0003 vs. 0.007 +/- 0.002 g/g body mass, h[Gly2]-GLP-2-treated vs. controls; P < 0.05) and small bowel weight (0.043 +/- 0.0037 vs. 0.031 +/- 0.0030 g/g body mass; P < 0.05). h[Gly2]-GLP-2 also increased both small (2.4 +/- 0.05 vs. 1.8 +/- 0.17 cm/g body mass; P < 0.05) and large bowel length (0.32 +/- 0.01 vs. 0.25 +/- 0.02 cm/g body mass, h[Gly2]-GLP-2-treated vs. saline-treated controls, respectively; P < 0.05) in neonatal rats. These findings demonstrate that both components of the GLP-2/GLP-2 receptor axis are expressed in the fetal and neonatal intestine. The ontogenic regulation and functional integrity of this axis raises the possibility that GLP-2 may play a role in the development and/or maturation of the developing rat intestine.


Subject(s)
Intestinal Mucosa/metabolism , Intestines/growth & development , Peptides/metabolism , Receptors, Glucagon/metabolism , Animals , Animals, Newborn , Colon/drug effects , Colon/growth & development , Gene Expression , Glucagon/genetics , Glucagon-Like Peptide 2 , Glucagon-Like Peptide-1 Receptor , Glucagon-Like Peptides , Intestine, Small/drug effects , Intestine, Small/growth & development , Intestines/embryology , Organ Size/drug effects , Peptides/analysis , Peptides/pharmacology , Proglucagon , Protein Precursors/genetics , RNA, Messenger/analysis , Rats , Rats, Wistar , Receptors, Glucagon/genetics , Reverse Transcriptase Polymerase Chain Reaction , Stomach/drug effects , Stomach/growth & development
2.
J Sleep Res ; 8(2): 157-9, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10389098

Subject(s)
Research , Sleep , Female , Humans , Male , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...